Skip to main content
MENU
Toggle navigation menu
Sign up
Log in
Baystate Health
Scholarly Commons Gallery
Expert Gallery
Follow
Contact
Selected Works of
Edward Reiter MD
Selected Works of
Save
Cancel
Pediatric Endocrinology
Title
Save
Cancel
read more
Works
About
×
About Edward Reiter MD
Positions
Present
Pediatric Endocrinology,
Baystate Health
Institution
Organization
Position Type
Position Title
Time Period
to
Options
Current Position
Affiliate my profile with this Institution
Save
Cancel
Disciplines
Medicine and Health Sciences
Title
URL
Funding Agency
Grant Name
Grant Number
Amount
$
Role
Colleague(s)
Time Period
to
Enter a valid date range.
Current Grant
Save
Cancel
Position
Affiliation
Time Period
to
Enter a valid date range.
Current Position
URL
Save
Cancel
Jump to Category
View All
Baystate Affiliated Publications
No Subject Area
No Subject Area
(49)
Issues in the management of Central Precocious Puberty
(Edward Reiter)
All Scholarly Works
(2009)
Metabolic abnormalities in human immunodeficiency virus-infected children: Two-year follow-up
(Maripat Toye, Jens Krause, Donna Fisher, et al.)
All Scholarly Works
(2009)
BACKGROUND: HIV-associated lipodystrophy (LD) manifests with fat maldistribution, dyslipidemia, and insulin resistance in some HIV-infected children on antiretroviral therapy. AIM: To assess whether lipid abnormalities in patients with HIV are stable over time. PATIENTS: The ...
Results of a second year of therapy with the 12-month Histrelin implant for the treatment of central precocious puberty
(Edward Reiter)
All Scholarly Works
(2009)
Consensus statement on the diagnosis and treatment of children with idiopathic short stature: A summary of the Growth Hormone Research Society, the Lawson Wilkins Pediatric Endocrine Society, and the European Society for Paediatric Endocrinology Workshop
(Edward Reiter)
All Scholarly Works
(2008)
OBJECTIVE: Our objective was to summarize important advances in the management of children with idiopathic short stature (ISS). PARTICIPANTS: Participants were 32 invited leaders in the field. EVIDENCE: Evidence was obtained by extensive literature review ...
Controversies in precocious puberty treatment
(Edward Reiter)
All Scholarly Works
(2008)
Issues in precocious puberty
(Edward Reiter)
All Scholarly Works
(2008)
New guidelines for GH treatment
(Edward Reiter)
All Scholarly Works
(2008)
Optimal hyperlipidemia monitoring in children and adolescents with type 1 diabetes mellitus
(Holley Allen, Dennis Brenner and Edward Reiter)
All Scholarly Works
(2008)
Idiopathic short stature: Management and growth hormone treatment
(Edward Reiter)
All Scholarly Works
(2008)
Public health implications of altered puberty timing
(Edward Reiter)
All Scholarly Works
(2008)
Normal and aberrant growth
(Edward Reiter)
All Scholarly Works
(2007)
Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
(Edward Reiter)
All Scholarly Works
(2007)
Efficacy and safety of histrelin subdermal implant in children with central precocious puberty: A multicenter trial
(Edward Reiter)
All Scholarly Works
(2007)
Growth hormone treatment to final height in idiopathic growth hormone deficiency: The KIGS experience
(Edward Reiter)
All Scholarly Works
(2007)
Small for gestational age: Short stature and beyond
(Edward Reiter)
All Scholarly Works
(2007)
Hormonal treatment of idiopathic short stature.
(Edward Reiter)
All Scholarly Works
(2007)
Major determinants of height development in Turner syndrome (TS) patients treated with GH: Analysis of 987 patients from KIGS.
(Edward Reiter)
All Scholarly Works
(2007)
Little is known about factors determining height outcome during GH treatment in Turner syndrome (TS). We investigated 987 TS children within the Kabi International Growth Study (KIGS) who had reached near adult height (NAH) after ...
Growth hormone treatment and adverse events in Prader-Willi syndrome: Data from KIGS (the Pfizer International Growth Database).
(Edward Reiter)
All Scholarly Works
(2006)
OBJECTIVE: To evaluate the response to recombinant GH treatment and adverse events in children with Prader-Willi syndrome (PWS) from KIGS, the Pfizer International Growth Database. PATIENTS: A total of 328 children (274 prepubertal, median age ...
A brief review of the addition of gonadotropin-releasing hormone agonists (GnRH-Ag) to growth hormone (GH) treatment of children with idiopathic growth hormone deficiency: Previously published studies from America.
(Edward Reiter)
All Scholarly Works
(2006)
Despite aggressive, early and continuous growth hormone (GH) treatment of children with idiopathic (I) growth hormone deficiency (GHD), height outcomes are often below -1 SDS and do not achieve mid-parental height targets. As pubertal growth ...
Testotoxicosis: Current viewpoint.
(Edward Reiter)
All Scholarly Works
(2005)
Testotoxicosis is a form of gonadotropin-independent (peripheral) precocious puberty in which boys experience early onset and progression of puberty. Patients have accelerated growth, early development of secondary sexual characteristics and usually reduc
HIV-associated lipodystrophy in children
(Barbara W Stechenberg, Holley Allen, Edward Reiter, et al.)
All Scholarly Works
(2005)
Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome.
(Holley Allen, Laura Koenigs, Nancy Miller, et al.)
All Scholarly Works
(2005)
OBJECTIVE: We evaluated the hypothesis that metformin would improve signs and symptoms of polycystic ovary syndrome (PCOS) in adolescents as compared to oral contraceptive pills (OCP) and have a favorable effect on obesity. STUDY DESIGN: ...
Increased response, but lower responsiveness, to growth hormone (GH) in very young children (aged 0-3 years) with idiopathic GH Deficiency: Analysis of data from KIGS.
(Edward Reiter)
All Scholarly Works
(2005)
In children, GH secretion and sensitivity to GH are influenced by developmental changes. It is not clear whether the response to GH in very young children with GH deficiency (GHD) is the same as that ...
Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age [Truncated Title]
(Edward Reiter)
All Scholarly Works
(2005)
BACKGROUND/AIMS: The beneficial effects of growth hormone (GH) therapy on statural growth in children are well established, but the effects on skeletal maturation are less clear. The progression of bone age (BA) was therefore studied ...
Final height in children with medulloblastoma treated with growth hormone.
(Edward Reiter)
All Scholarly Works
(2005)
BACKGROUND: Medulloblastoma is the most frequent primary solid central nervous system tumour in children. The 5-year survival rate is at present at about 60%. Height in general is severely compromised in survivors. The present study ...
More